Found 5 matching trials
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation PHASE3 Depemokimab is being developed as a treatment for individuals with moderate...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype PHASE3 This is a multi-center, randomized, placebo-controlled, double-blind, paral...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype PHASE3 This study will assess whether switching participants who have benefitted f...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) PHASE3 This study aims to investigate the efficacy and safety of depemokimab compa...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial PHASE3 This is a 52-week, randomized, placebo-controlled, double-blind, parallel g...
Show More Location
GSK Investigational Site
Learn More & Join Trial